search results for 
Logo

26. Noncontrolling interest

NONCONTROLLING INTEREST SUBJECT TO PUT PROVISIONS

The Fresenius Group has potential obligations to purchase the noncontrolling interests held by third parties in certain of its consolidated subsidiaries. These obligations are in the form of put provisions and are exercisable at the third-party owners’ discretion within specified periods as outlined in each specific put provision. If these put provisions were exercised, the Fresenius Group would be required to purchase all or part of third-party owners’ noncontrolling interests at the appraised fair value at the time of exercise.

As of December 31, 2011 and 2010 the Fresenius Group’s potential obligations under these put options were €317 million and €209 million, respectively, of which, at December 31, 2011, €88 million were exercisable.

NONCONTROLLING INTEREST NOT SUBJECT TO PUT PROVISIONS

As of December 31, noncontrolling interest not subject to put provisions in the Group was as follows:

€ in millions 2011 2010
Noncontrolling interest not subject to put provisions in Fresenius Medical Care AG & Co. KGaA 4,254 3,574
Noncontrolling interest not subject to put provisions in HELIOS Kliniken GmbH 0 4
Noncontrolling interest not subject to put provisions in VAMED AG 28 23
Noncontrolling interest not subject to put provisions in the business segments    
Fresenius Medical Care 123 110
Fresenius Kabi 63 46
Fresenius Helios 136 119
Fresenius Vamed 2 3
Total noncontrolling interest not subject to put provisions 4,606 3,879

€ in millions 2011 2010
Noncontrolling interest not subject to put provisions in Fresenius Medical Care AG & Co. KGaA 4,254 3,574
Noncontrolling interest not subject to put provisions in HELIOS Kliniken GmbH 0 4
Noncontrolling interest not subject to put provisions in VAMED AG 28 23
Noncontrolling interest not subject to put provisions in the business segments    
Fresenius Medical Care 123 110
Fresenius Kabi 63 46
Fresenius Helios 136 119
Fresenius Vamed 2 3
Total noncontrolling interest not subject to put provisions 4,606 3,879

Due to the maturity of the Mandatory Exchangeable Bonds on August 14, 2011, Fresenius SE & Co. KGaA’s shareholding in Fresenius Medical Care AG & Co. KGaA (FMC-AG & Co. KGaA) was reduced by 15,722,644 ordinary shares to 30.4% of the ordinary share capital. In November and December 2011, Fresenius SE & Co. KGaA purchased 1,399,996 ordinary shares of FMC-AG & Co. KGaA. Therewith, Fresenius SE & Co. KGaA’s shareholding in FMC-AG & Co. KGaA amounted to 30.74% of the ordinary share capital at December 31, 2011.

Noncontrolling interest not subject to put provisions changed as follows:

€ in millions 2011
Noncontrolling interest not subject to put provisions at December 31, 2010 3,879
Noncontrolling interest not subject to put provisions in profit 605
Maturity of the Mandatory Exchangeable Bonds 298
Dividend payments -192
Purchase of ordinary shares of FMC-AG & Co. KGaA -28
Stock options, currency effects and first-time consolidations 44
Noncontrolling interest not subject to put provisions at December 31, 2011 4,606

€ in millions 2011
Noncontrolling interest not subject to put provisions at December 31, 2010 3,879
Noncontrolling interest not subject to put provisions in profit 605
Maturity of the Mandatory Exchangeable Bonds 298
Dividend payments -192
Purchase of ordinary shares of FMC-AG & Co. KGaA -28
Stock options, currency effects and first-time consolidations 44
Noncontrolling interest not subject to put provisions at December 31, 2011 4,606

QUICKFINDER

History

Tools